摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-碘-6H-苯并咪唑并[2,1-b]喹唑啉-12-酮 | 32701-17-0

中文名称
2-碘-6H-苯并咪唑并[2,1-b]喹唑啉-12-酮
中文别名
——
英文名称
2-iodobenzimidazo[2,1-b]quinazolin-12(6H)-one
英文别名
2-iodo-5H-benzo[4,5]imidazo[2,1-b]quinazolin-12-one;2-iodobenzimidazo[2,1-b]quinazolin-12(6H)one;2-Iodo-benzimidazo<1,2-b>chinazolin-12(6H)-on;Benzimidazo(2,1-b)quinazolin-12(6H)-one, 2-iodo-;2-iodo-6H-benzimidazolo[2,1-b]quinazolin-12-one
2-碘-6H-苯并咪唑并[2,1-b]喹唑啉-12-酮化学式
CAS
32701-17-0
化学式
C14H8IN3O
mdl
——
分子量
361.142
InChiKey
GFYBDLLHTVOEHC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    612.0±57.0 °C(Predicted)
  • 密度:
    2.01±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    19
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    44.7
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:fa0ca8e38fd1a2ff5637c4ded1350670
查看

反应信息

  • 作为产物:
    描述:
    2-thio-3-methyl-6-iodo-4(3H)-quinazolinone 在 sodium hydroxide 作用下, 以 melt 、 为溶剂, 反应 21.0h, 生成 2-碘-6H-苯并咪唑并[2,1-b]喹唑啉-12-酮
    参考文献:
    名称:
    New general synthesis of benzo[4,5]imidazo[1,2-a]pyrimidine and benzo[4,5]imidazo[2,1-b]quinazoline derivatives
    摘要:
    The reactions of benzene-1,2-diamine with 5-substituted 2-(alkylsulfanyl)-4-methylpyrimidin-6(1H)-ones and 2-(propylsulfanyl)- and 5-iodo-2-(propylsulfanyl)-3,4-dihydroquinazolines at 175-185A degrees C under solvent-free conditions unexpectedly afforded benzo[4,5]imidazo[1,2-a]pyrimidine, benzo[4,5]imidazo[2,1-b]-quinazoline, and 2,2'-(benzene-1,2-diyldiimino)bis[pyrimidin-4(3H)-ones]. The described reaction is the first example of synthesis of these heterocyclic systems by fusion of benzimidazole to pyrimidine or quinazoline and is likely to follow ANRORC mechanism.
    DOI:
    10.1134/s1070428016070150
点击查看最新优质反应信息

文献信息

  • Immunosuppressants
    申请人:Eli Lilly and Company
    公开号:US04000275A1
    公开(公告)日:1976-12-28
    Benzimidazo[2,1-b]quinazolin-12(6H)ones, immunosuppressives and agents for treatment of auto-immune diseases, are prepared via (1) reacting a 2-chlorobenzimidazole with an anthranilic acid or ester; (2) reacting a 2-aminobenzimidazole with an anthranilic acid or ester in the presence of trifluoroacetic acid or (3) reacting a 2-methylmercaptobenzimidazole with an anthraniloyl halide hydrohalide.
    Benzimidazo[2,1-b]quinazolin-12(6H)ones是一种免疫抑制剂和治疗自身免疫疾病的药物,制备方法如下:(1)将2-氯苯并咪唑与吗啉酸或酯反应;(2)在三氟乙酸存在下,将2-氨基苯并咪唑与吗啉酸或酯反应;(3)将2-甲基硫代苯并咪唑与吗啉酰卤化物水合物反应。
  • US4000275A
    申请人:——
    公开号:US4000275A
    公开(公告)日:1976-12-28
  • New general synthesis of benzo[4,5]imidazo[1,2-a]pyrimidine and benzo[4,5]imidazo[2,1-b]quinazoline derivatives
    作者:A. A. Harutyunyan
    DOI:10.1134/s1070428016070150
    日期:2016.7
    The reactions of benzene-1,2-diamine with 5-substituted 2-(alkylsulfanyl)-4-methylpyrimidin-6(1H)-ones and 2-(propylsulfanyl)- and 5-iodo-2-(propylsulfanyl)-3,4-dihydroquinazolines at 175-185A degrees C under solvent-free conditions unexpectedly afforded benzo[4,5]imidazo[1,2-a]pyrimidine, benzo[4,5]imidazo[2,1-b]-quinazoline, and 2,2'-(benzene-1,2-diyldiimino)bis[pyrimidin-4(3H)-ones]. The described reaction is the first example of synthesis of these heterocyclic systems by fusion of benzimidazole to pyrimidine or quinazoline and is likely to follow ANRORC mechanism.
查看更多